NSF names Center for Computer-Assisted Synthesis a Phase II Center for Chemical Innovation
Imagine a world where the power of chemistry is used in concert with machine learning to solve problems in health care, materials science or energy research. Machine learning can accelerate the synthesis of molecules that hold the key to solving these problems by developing new and more efficient ways of making them.
The Center for Computer-Assisted Synthesis (C-CAS) — recently named one of only seven Phase II National Science Foundation Centers for Chemical Innovation (CCI) in the nation, and the first one in Indiana — will change the way chemists solve these problems and many more, both quickly and effectively. To do so, the National Science Foundation awarded C-CAS $20 million over five years.
“C-CAS is building a future where a chemist designs a new molecule and uses AI to work out how to best make that molecule,” said Sean L. Jones, assistant director of the Directorate of Mathematical and Physical Sciences at the NSF. “This will allow industries including pharmaceuticals, biotechnology, fine chemicals, electronics and more to make molecules more sustainably and affordably. This is a grand research challenge with huge societal impact.”
C-CAS helps chemists focus on which molecules should be made, rather than on how to make them. By reducing the time and resources needed to design and optimize synthetic routes, the tools and protocols developed in C-CAS provide data-driven approaches to make synthetic chemistry more predictable and efficient because less time is spent on trial-and-error approaches. The tools developed by C-CAS are then shared with the research community through open-source clearinghouses.
C-CAS will also contribute to making the United States a leader in science and technology through attracting, educating and training a new generation of “data chemists” that includes novel opportunities for researchers from underrepresented groups.
C-CAS is a nexus of collaboration, innovation and education whose impact is amplified by an extensive network of academic researchers, companies, nonprofits and other research centers. This provides C-CAS with a unique opportunity to help shape the future of synthetic chemistry and the fields that rely on it such as medicine, materials and energy.
The CCI Program is a highly competitive, two-phase program. Phase I CCIs receive resources to develop the science, management and broader impact components of a major research center dedicated to a transformative idea before requesting Phase II funding.
“With its collaborative network of data scientists, computer scientists and synthetic and computational chemists, C-CAS is poised to introduce potentially paradigm-shifting approaches,” said David Berkowitz, the director of the NSF Division of Chemistry. “This Center for Chemical Innovation promises to add an important data-driven dimension to synthesis to complement the intuition of the synthetic chemist, while building on the principles of mechanistic understanding, atom economy, symmetry and convergency.”
C-CAS is led by Olaf Wiest, professor in the Department of Chemistry and Biochemistry at Notre Dame, and brings together the expertise of data scientists and computational and synthetic chemists to change the field of synthetic chemistry from an intuition-driven to a data-driven science. Collaborators at Notre Dame include principal investigators Nitesh Chawla, the Frank M. Freimann Professor of Computer Science and Engineering, and Xiangliang Zhang, associate professor of computer science and engineering.
"Over the last 15 years, chemists have learned to generate much bigger datasets using computation and high throughput experimentation, but are often not equipped to take full advantage of them,” said Wiest. “C-CAS will develop and share the concepts, datasets and tools to transform the practice of synthesis by maximizing the value of a quantitative approach to data analysis."
External faculty affiliates include Connor Coley at MIT, Abby Doyle and Wei Wang at UCLA, Gabriel Gomes and Olexandr Isayev at Carnegie Mellon University, Hosea Nelson and Sarah Reisman at CalTech, Rob Paton at Colorado State University, Richmond Sarpong and Dean Toste at UC-Berkeley, and Matthew Sigman at the University of Utah.
An important part of C-CAS is the Data Chemists Network, a group of faculty with distinguished expertise ranging from synthetic chemistry to science communication at institutions that typically do not participate in large research centers. The perspectives and skills of Raychelle Burks at American University, Andre Isaacs at College of the Holy Cross, Nicholas Ball at Pomona College, Jessica Kisunzu at Colorado College, and Ampofo Darko at University of Tennessee therefore greatly enhance the reach and capabilities of C-CAS.
C-CAS is funded by NSF through CHE-2202693. For additional information on C-CAS, visit ccas.nd.edu
Originally published by science.nd.edu on Aug. 11.
atLatest Faculty & Staff
- Opioid epidemic reaches beyond health impacts to influence politicsVicky Barone, assistant professor of economics at Notre Dame, researched the origins and development of the opioid epidemic and found that the unregulated marketing of potent painkillers led to increased access to prescription opioids and subsequent overdose mortalities. Tracing the long-term consequences of opioid overdose deaths on the political landscape in America, she found an increased support for conservative beliefs and Republican candidates.
- Doug Thompson appointed inaugural executive director of diversity and engagementDoug Thompson, current vice president for equity and inclusion at Gustavus Adolphus College, has been appointed as the inaugural executive director of diversity and engagement in the University of Notre Dame’s Division of Student Affairs, effective July 1.
- There’s no ‘one size fits all’ when it comes to addressing men’s health issues globallyAt a time when health resources are at a premium and need to be wisely allocated, health professionals must find points within men’s lives when it makes the most sense to intervene and advocate for preventive care for promoting better health outcomes. Life transitions such as marriage and fatherhood are often pivotal and crucial intervention points. But just like every man is different, health concerns across global communities differ as well. Research from the University of Notre Dame finds that not all life transitions produce the same health results, and not all men’s global health policies should look the same from one country to another.
- Three Notre Dame faculty named 2024 Guggenheim FellowsBarbara Montero, a professor of philosophy; Gretchen Reydams-Schils, a professor in the Program of Liberal Studies; and Roy Scranton, an associate professor of English and director of the Creative Writing Program and the Environmental Humanities Initiative, are among the 188 scholars, scientists and artists chosen from approximately 3,000 applicants for the fellowship. The Guggenheim Foundation awards these fellowships to outstanding scholars in order to add to the educational, literary, artistic and scientific power of the country.
- Essays on democracy draw attention to critical threats, explore safeguards ahead of Jan. 6Shortly after Jan. 6, 2021, when a mob stormed the U.S. Capitol building, Notre Dame’s Rooney Center for the Study of American Democracy established the January 6th, 2025, Project, which includes 10 Notre Dame faculty who are preeminent scholars of democracy. In an effort to understand the social, political, psychological and demographic factors that led to that troublesome day, the group created a collection of 14 essays aimed at drawing attention to the vulnerabilities in our democratic system and the threats building against it, hoping to create consensus on ways to remedy both problems.
- Carter Snead testifies before US Senate Judiciary CommitteeO. Carter Snead, the Charles E. Rice Professor of Law and director of the de Nicola Center for Ethics and Culture at the University of Notre Dame, offered expert testimony on Wednesday (March 20) before the U.S. Senate Committee on the Judiciary on the current legal landscape following the landmark Supreme Court decision in Dobbs v. Jackson Women’s Health Organization.